Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
Isoquercetin in Ovarian Serous Tumor: NCT07303894 Clinical Landscape Report 2026
15 October 2026
NCT07303894 clinical landscape for Ovarian Serous Tumor: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
GC-012F in Multiple Sclerosis: NCT07303790 Clinical Landscape Report 2026
15 October 2026
NCT07303790 clinical landscape for Multiple Sclerosis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Olutasidenib in IDH1 Mutation Acute Myeloid Leukemia: NCT07304011 Clinical Landscape Report 2026
15 October 2026
NCT07304011 clinical landscape for IDH1 Mutation Acute Myeloid Leukemia: endpoints, sponsor, phase, geography, readouts, asset context and development white…
9 min read
Pivekimab Sunirine in Refractory acute myeloid leukemia: NCT07306832 Clinical Landscape Report 2026
15 October 2026
NCT07306832 clinical landscape for Refractory acute myeloid leukemia: endpoints, sponsor, phase, geography, readouts, asset context and development white spa…
9 min read
Eiletoclax in Acute Myeloid Leukemia: NCT07303660 Clinical Landscape Report 2026
15 October 2026
NCT07303660 clinical landscape for Acute Myeloid Leukemia: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Tofacitinib Citrate in Psoriasis of nail: NCT07313072 Clinical Landscape Report 2026
15 October 2026
NCT07313072 clinical landscape for Psoriasis of nail: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Drotokibart in Moderate Atopic Dermatitis: NCT07309055 Clinical Landscape Report 2026
15 October 2026
NCT07309055 clinical landscape for Moderate Atopic Dermatitis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Sacituzumab tirumotecan in Recurrent Platinum-Resistant Ovarian Carcinoma: NCT07314619 Clinical Landscape Report 2026
15 October 2026
NCT07314619 clinical landscape for Recurrent Platinum-Resistant Ovarian Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and developm…
9 min read
Nomelcitinib in Arthritis, Psoriatic: NCT07315061 Clinical Landscape Report 2026
15 October 2026
NCT07315061 clinical landscape for Arthritis, Psoriatic: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Carboplatin in HRD-positive Ovarian Cancer: NCT07311577 Clinical Landscape Report 2026
15 October 2026
NCT07311577 clinical landscape for HRD-positive Ovarian Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Melatonin in Plaque psoriasis: TCTR20251231009 Clinical Landscape Report 2026
15 October 2026
TCTR20251231009 clinical landscape for Plaque psoriasis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
TQH2929 in Generalized Pustular Psoriasis: NCT07314060 Clinical Landscape Report 2026
15 October 2026
NCT07314060 clinical landscape for Generalized Pustular Psoriasis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.